 |
Welcome to Newsbank 17
Welcome to our first Life Sciences newsletter under the College Hill brand. The College Hill Life Sciences team was significantly expanded last year, with the acquisition of Northbank Communications into College Hill. Our 25-strong team now serves some 100 clients in over 15 countries, offering a full range of communications services – meeting clients’ financial, corporate, marketing and healthcare communications needs.
All industries are being affected by the global “credit crunch” – not least companies in the life sciences sector that operate at the high-risk end of the spectrum. As the going gets tough, we are working with our clients to find ever more creative and cost effective ways to help them meet their communications objectives. Over the last few months we have successfully completed many campaigns and projects for clients and been successful in attracting new clients.
I hope this newsletter will give you a taster of the capabilities of College Hill’s Life Sciences team – I look forward to hearing from you if you’d like to find out more.
|
|
Positive Results
Acambis called upon College Hill’s media relations skills when it wanted to maximise the announcement of positive results for both a Phase I trial and a preclinical trial that tested the ability of the Acambis flu vaccine to tackle H5N1 influenza. College Hill’s Life Sciences team worked closely with the Acambis team to create significant national and international media interest and coverage.
View Case Study |
|
Award Winning Clients
Congratulations to two of our retained clients for winning prestigious industry awards. At the 3rd Annual Scrip Awards ceremony Oxford BioMedica, won the Licensing Deal of the Year award for its exclusive global licensing agreement with Sanofi-Aventis to develop and commercialise TroVax® for cancer treatment and prevention. While in March, at the PLC Awards Dinner, Corin won ‘Best Performing Share of the Year’ Award. Corin’s share price rose sharply after receiving key FDA approval to market its metal-on-metal hip resurfacing product Cormet, in the US and announcing a partnering deal with Stryker, the orthopedics giant.
View Oxford BioMedica’s Press Release
View Corin’s Press Release
|
|
Launching The Change
Following on from the creation of a new corporate design style and its name change from Nimbus Biotechnologie to Sovicell, a new website was created by College Hill’s Life Science team that played a key role in fulfilling the Company’s move towards becoming a full range supplier of ADME-Tox products and services. The launch was co-ordinated with College Hill’s Life Science team issuing a press release to announce the Company’s name change.
View Case Study
|
|
|
| News |
Events We Are Supporting |
 |
College Hill’s Life Sciences team has been appointed by Index Ventures, Geneva, Switzerland to develop and implement a PR programme to raise the profile of Index as a leading venture investor in the life sciences arena globally, in particular amongst the pharmaceutical industry, innovators and within the venture capital community. More... |
 |
College Hill’s Life Sciences team supported GE Healthcare by effectively promoting its IN CELL Analyzer range of products to the scientific community and beyond through an Image competition. More... |
 |
Building on past successful conferences and working together with its events partner Gemini International, College Hill’s Life Sciences team was called in again to help with the successful promotion and management of this year’s 4th Genomes to Systems Conference. More... |
 |
February saw the launch of the 2008 London Technology Fund Competition, which is being supported by College Hill’ Life Sciences team. The competition will see London based companies compete for a share of up to £1 million investment. More... |
New Biz: In recent months, College Hill’s Life Sciences team has started working with a number of new clients including: Activaero, Aquapharm, Cogenics, Fulcrum Pharma, Gastrotech, Index Ventures, Intermed, KSV Instruments, Novacta, Polyphor, Pronostics,
ReGen Therapeutics, Sloning BioTechnology, U3 Pharma and Westover
For our full client list, click here 
Conference Roundup: PepTalk 2008, BioSquare 2008, More...
|
|
|
|
| Meet Us At |
| Date |
Event |
Location |
Attending |
| 15-16 Apr 2008 |
BioTrinity 2008 |
Oxford, UK |
Katja Stout |
| 22-23 Apr 2008 |
European Life Science CEO Forum for Investing & Partnering in Biotech, Medtech, Speciality Pharma & Emerging Markets |
Zurich, Switzerland |
Douglas Pretsell, Justine Lamond |
| 7-9 May 2008 |
ERBI 10th Anniversary Biopartnering Exchange |
Cambridge, UK |
Lorna Cuddon, Katie Odgaard |
| 8 May 2008 |
BioVaria 2008 |
Munich, Germany |
Douglas Pretsell |
| 28-29 May 2008 |
Bio€quity Europe 2008 |
Amsterdam, Netherlands |
Sue Charles, Adam Michael |
| 9 Jun 2008 |
BioFinance and Bioinnovate Europe 08 |
London, UK |
Justine Lamond |
| 17-20 Jun 2008 |
BIO International Convention |
San Diego, USA |
Katja Stout |
| 26 Jun 2008 |
Mediscience Awards Dinner |
London, UK |
Sue Charles, Katja Stout, Adrian Duffield |
| 23-24 Sep 2008 |
Biotech in Europe Investor Forum |
Zurich, Switzerland |
Douglas Pretsell, Justine Lamond |
|
| People |
| Here are some team additions and promotions: |
|
|
|
|
